Literature DB >> 22885806

Apoptotic-like death occurs through a caspase-independent route in colon carcinoma cells undergoing mitotic catastrophe.

Laia Llovera1, Sylvia Mansilla, José Portugal.   

Abstract

We have examined the relationship between chemotherapy-induced mitotic catastrophe and cell death by apoptosis in both wild-type and p53(-/-) HCT116 human colon carcinoma cells treated with nanomolar concentrations of paclitaxel (PTX), a drug that acts on tubulin altering the normal development of mitosis. After treatment, HCT116 cells entered mitosis regardless of the presence of functional p53, which resulted in changes in the distribution of cells in the different phases of the cell cycle, and in cell death. In the presence of PTX, the percentage of polyploid cells observed was higher in p53-deficient cells, indicating that mitotic slippage was favored compared to wild-type cells, with the presence of large multinucleate cells. PTX caused mitotic catastrophe and about 50-60% cells that were entering an aberrant mitosis died through an apoptotic-like pathway characterized by the presence of phosphatidylserine in the outer cell membrane, which occurred in the absence of significant activation of caspases. Lack of p53 facilitated endoreduplication and polyploidy in PTX-treated cells, but cells were still killed with similar efficacy through the same apoptotic-like mechanism in the absence of caspase activity.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885806     DOI: 10.1016/j.canlet.2012.08.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.

Authors:  Zhaoshi Bai; Meiqi Gao; Xiaobo Xu; Huijuan Zhang; Jingwen Xu; Qi Guan; Qing Wang; Jianan Du; Zhengqiang Li; Daiying Zuo; Weige Zhang; Yingliang Wu
Journal:  Cell Prolif       Date:  2018-03-01       Impact factor: 6.831

2.  Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer.

Authors:  J Tang; Y Li; K Lyon; J Camps; S Dalton; T Ried; S Zhao
Journal:  Oncogene       Date:  2013-02-18       Impact factor: 9.867

3.  Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status.

Authors:  Hind Hafsi; Magnus T Dillon; Holly E Barker; Joan N Kyula; Ulrike Schick; James T Paget; Henry G Smith; Malin Pedersen; Martin McLaughlin; Kevin J Harrington
Journal:  Front Oncol       Date:  2018-07-13       Impact factor: 6.244

4.  Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.

Authors:  Monica M Montano; I-Ju Yeh; Yinghua Chen; Chris Hernandez; Janna G Kiselar; Maria de la Fuente; Adriane M Lawes; Marvin T Nieman; Philip D Kiser; James Jacobberger; Agata A Exner; Matthew C Lawes
Journal:  Breast Cancer Res       Date:  2019-12-05       Impact factor: 6.466

Review 5.  Non-Canonical Programmed Cell Death in Colon Cancer.

Authors:  Bingchen Pan; Bowen Zheng; Chengzhong Xing; Jingwei Liu
Journal:  Cancers (Basel)       Date:  2022-07-07       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.